TNFSF10 and cancer: In addition, we recently showed that TRAIL/TRAIL‐R exerts death domain (DD)‐independent, pro‐tumorigenic and pro‐metastatic functions in KRAS‐mutated cancer cells (von Karstedt et al, 2015).